Interpore Bone Treatment Gets OK
<i> Dow Jones</i>
Interpore Cross International said Tuesday its new bone plate system for treating internal pelvic fractures has been cleared by the Food and Drug Administration. The Irvine medical device company expects the system to be ready for market launch as early as first quarter 1999.
Interpore’s stock was unchanged Tuesday at $4.63.
